Inventory, Net of IDEXX LABORATORIES INC /DE from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
IDEXX LABORATORIES INC /DE quarterly Inventory, Net in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Inventory, Net for the quarter ending 30 Sep 2025 was $391,564,000, a 0.45% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $391,564,000 +$1,760,000 +0.45% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $392,584,000 +$12,626,000 +3.3% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $395,987,000 +$5,388,000 +1.4% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $381,877,000 +$1,595,000 +0.42% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $389,804,000 -$4,170,000 -1.1% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $379,958,000 -$15,183,000 -3.8% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $390,599,000 -$412,000 -0.1% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $380,282,000 +$12,459,000 +3.4% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $393,974,000 +$38,999,000 +11% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $395,141,000 +$62,576,000 +19% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $391,011,000 +$89,373,000 +30% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $367,823,000 +$98,793,000 +37% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $354,975,000 +$96,491,000 +37% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $332,565,000 +$91,173,000 +38% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $301,638,000 +$76,079,000 +34% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $269,030,000 +$59,157,000 +28% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $258,484,000 +$40,887,000 +19% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $241,392,000 +$12,015,000 +5.2% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $225,559,000 +$13,915,000 +6.6% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $209,873,000 +$14,854,000 +7.6% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $217,597,000 +$12,704,000 +6.2% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $229,377,000 +$32,501,000 +17% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $211,644,000 +$22,176,000 +12% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $195,019,000 +$21,716,000 +13% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $204,893,000 +$25,209,000 +14% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $196,876,000 +$20,389,000 +12% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $189,468,000 +$10,429,000 +5.8% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $173,303,000 +$8,985,000 +5.5% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $179,684,000 +$2,935,000 +1.7% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $176,487,000 +$6,794,000 +4% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 $179,039,000 +$6,856,000 +4% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 $164,318,000 +$6,284,000 +4% 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q3 2017 $176,749,000 +$8,281,000 +4.9% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $169,693,000 -$5,995,000 -3.4% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 $172,183,000 -$11,576,000 -6.3% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $158,034,000 -$30,799,000 -16% 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q3 2016 $168,468,000 -$23,937,000 -12% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 $175,688,000 -$8,812,000 -4.8% 30 Jun 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 $183,759,000 +$10,389,000 +6% 31 Mar 2016 10-Q 29 Apr 2016 2016 Q1
Q4 2015 $188,833,000 +$28,491,000 +18% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $192,405,000 +$36,398,000 +23% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $184,500,000 +$39,100,000 +27% 30 Jun 2015 10-Q 30 Jul 2015 2015 Q2
Q1 2015 $173,370,000 +$32,236,000 +23% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $160,342,000 +$26,915,000 +20% 31 Dec 2014 10-K 17 Feb 2016 2015 FY
Q3 2014 $156,007,000 +$10,020,000 +6.9% 30 Sep 2014 10-Q 24 Oct 2014 2014 Q3
Q2 2014 $145,400,000 +$4,462,000 +3.2% 30 Jun 2014 10-Q 25 Jul 2014 2014 Q2
Q1 2014 $141,134,000 -$7,108,000 -4.8% 31 Mar 2014 10-Q 25 Apr 2014 2014 Q1
Q4 2013 $133,427,000 -$7,519,000 -5.3% 31 Dec 2013 10-K 17 Feb 2015 2014 FY
Q3 2013 $145,987,000 -$1,487,000 -1% 30 Sep 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 $140,938,000 -$2,765,000 -1.9% 30 Jun 2013 10-Q 23 Jul 2013 2013 Q2
Q1 2013 $148,242,000 +$7,138,000 +5.1% 31 Mar 2013 10-Q 23 Apr 2013 2013 Q1
Q4 2012 $140,946,000 +$7,847,000 +5.9% 31 Dec 2012 10-K 18 Feb 2014 2013 FY
Q3 2012 $147,474,000 +$10,331,000 +7.5% 30 Sep 2012 10-Q 19 Oct 2012 2012 Q3
Q2 2012 $143,703,000 +$9,769,000 +7.3% 30 Jun 2012 10-Q 20 Jul 2012 2012 Q2
Q1 2012 $141,104,000 +$14,050,000 +11% 31 Mar 2012 10-Q 20 Apr 2012 2012 Q1
Q4 2011 $133,099,000 +$5,214,000 +4.1% 31 Dec 2011 10-K 19 Feb 2013 2012 FY
Q3 2011 $137,143,000 +$5,588,000 +4.2% 30 Sep 2011 10-Q 21 Oct 2011 2011 Q3
Q2 2011 $133,934,000 +$11,902,000 +9.8% 30 Jun 2011 10-Q 22 Jul 2011 2011 Q2
Q1 2011 $127,054,000 31 Mar 2011 10-Q 21 Apr 2011 2011 Q1
Q4 2010 $127,885,000 31 Dec 2010 10-K 17 Feb 2012 2011 FY
Q3 2010 $131,555,000 30 Sep 2010 10-Q 22 Oct 2010 2010 Q3
Q2 2010 $122,032,000 30 Jun 2010 10-Q 23 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.